Activella
From Wikipedia, the free encyclopedia
 |
This article does not cite any references or sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. (December 2006) |
| Combination of | |
|---|---|
| Estradiol | Estrogen |
| Norethindrone | Progestogen |
| Clinical data | |
| AHFS/Drugs.com | monograph |
| MedlinePlus | a601041 |
| Pregnancy cat. | X(US) |
| Legal status | ℞-only (US) |
| Identifiers | |
| ATC code | G03FA01 |
 (what is this?) (verify) |
|
Activella is a combination drug of estradiol and norethindrone acetate used for the treatment of vasomotor symptoms, vulvar and vaginal atrophy and osteoporosis associated with menopause.
Activella supplied as film-coated tablets containing 1 mg estradiol and 0.5 mg norethindrone acetate. Activella is marketed by Novo Nordisk.
 |
This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it. |
